
这个市场不值得进入,已经明显进入价格战区,不适合大品牌也不适合小商家。 现在的核心事实很清楚:新品牌只有12个,但新发布产品36个里,真正盈利的只有16.67%,而新产品整体盈利率也只有14.71%,82.35%都没跑出来;利润区间从1.70%到27.28%,大量产品集中在10%以下,说明不是健康竞争,而是低毛利互砍。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这不是适合进入的市场:预算够用,但市场已经明显偏向价格战和大品牌主导,成功率不支持新手或小商家重仓进入。 你的 50万 CNY 只能覆盖单个新品前期启动,和市场里少数可见的低成本新品门槛接近,但这不代表能长期跑赢;真正的问题是,市场新品牌新品盈利率只有 17.65%,新品牌新品亏损率高达 76.47%,而整体可识别盈利产品比例也只有 38.35%,说明不是“有机会”,而是“多数人会亏”。
证据很直接:低门槛新品的可复制利润并不稳定。 目前可见的高性价比成功样本是 Arme 的 B0FMDGFLXP,单品预算约 2,474.85 美元,售价 9.61 美元,毛利率 15.07%,月销 6,000,月收 57.66 万美元;但它依赖“多形状功能区分 + 旧款基础上微创新”。反面样本 Amasodaon 的 B0FR98ZBXH,预算同样约 2,474.85 美元,售价 6.33 美元,毛利率只有 -2.05%,虽然有 216 条评论但仍不盈利;Amazon Basics 的 B0GWFYT26R 也是新入场却只有 4.38% 毛利,说明低价并不能撑利润。大品牌方面,Band-Aid 的 B0G21PYJ76 售价 9.29 美元、毛利率 11.27%、14,044 条评论、月销 4,000,B0G227RM3L 毛利率更高到 23.18%、14,045 条评论、月销 4,000,属于典型的大品牌带流量模型;但它的新品里也有 4 个亏损、2 个盈利,说明连老牌都在承受新产品筛选压力。小商家如果想进,唯一能参考的是真正的新品牌成功案例 Arme 这类“低预算、强功能差异、低评论压力”的单品,而不是 Band-Aid 这类老品牌。
结论:不建议进入;如果一定要做,只能照着少数成功样本做极窄差异化,而且要接受高失败概率。 大品牌可参考 Band-Aid 的 B0G227RM3L、B0G21PYJ76;小商家只该参考 Arme 的 B0FMDGFLXP,别拿老品牌当小商家模板。这个市场没有 oversaturation 到“30~100+ 新品牌”那种硬证据,但已经很接近价格战区:很多新产品利润都在 10% 附近甚至更低,且亏损新品牌占比远高于盈利新品牌;如果你没有明显功能创新、强供应链和足够测试预算,进入后更像是替别人烧钱。
Some categories may not originally require certain certificates for entry; however, some products may target specific features (e.g. Bluetooth) or customers (e.g. children), and additional certificates may be required in the target marketplace (e.g. FCC, CPC).
Alternative solutions may pose a risk to your investment in certain markets.
结论很直接:这个市场不值得现在进入,已经明显接近/进入饱和和价格战区。 新品牌进入已达到12个,新增产品36个,而新上架产品只有16.67%盈利;同时市场盈利分布里10%以下利润的产品很多,说明低利润竞争很重,不适合小品牌硬冲,也不适合大品牌去靠规模硬压。
这不是适合现在进入的市场:利润被压到低位,新品牌成功率也不高,整体已经明显偏向价格战和品牌垄断。 用户预算50万人民币表面上够覆盖单个ASIN的前期投入,但真实门槛并不在起步资金,而在品牌力、差异化和长期投入;按当前数据,小商家直接硬闯风险很高。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B07LCRX2M7 | Dr. Frederick's Original | 2018-12-23 | Yes | $13.99 | 5000pcs | $69950.0 | 29.0% | $20285.5 |
![]() | B0DDTCD6JT | Promifun | 2024-09-30 | Yes | $19.74 | 3000pcs | $59220.0 | 28.96% | $17150.12 |
![]() | B0D76DCW3S | Promifun | 2024-07-13 | Yes | $14.79 | 4000pcs | $59160.0 | 26.75% | $15825.3 |
![]() | B0G227RM3L | Band-Aid | 2025-11-12 | Yes | $12.93 | 4000pcs | $51720.0 | 23.18% | $11988.7 |
![]() | B0CFSZMLTR | Welly | 2023-09-01 | Yes | $10.84 | 9000pcs | $97560.0 | 12.11% | $11814.52 |
![]() | B0DDT9KN2C | Promifun | 2024-09-08 | Yes | $14.25 | 3000pcs | $42750.0 | 27.24% | $11645.1 |
![]() | B0DYDPKBNW | Kimihome | 2025-01-06 | Yes | $13.99 | 3000pcs | $41970.0 | 27.22% | $11424.24 |
![]() | B0GHSNJPP2 | Viybtue | 2026-01-20 | Yes | $16.9 | 3000pcs | $50700.0 | 19.27% | $9769.89 |
![]() | B08ZJ6BSCR | Dimora | 2021-03-19 | Yes | $15.13 | 2000pcs | $30260.0 | 28.87% | $8736.07 |
![]() | B0FMDGFLXP | Arme | 2025-08-24 | Yes | $9.61 | 6000pcs | $57660.0 | 15.07% | $8689.37 |
![]() | B0DKXTXKZG | JXXAMZ33 | 2024-10-25 | Yes | $8.85 | 6000pcs | $53100.0 | 13.24% | $7030.44 |
![]() | B0DJ2Y51M1 | Promifun | 2024-10-18 | Yes | $10.03 | 3000pcs | $30090.0 | 19.24% | $5789.32 |
![]() | B0CX6D15GV | quitch | 2024-03-05 | Yes | $9.45 | 3000pcs | $28350.0 | 18.35% | $5202.23 |
![]() | B0FMXLXDRL | TINBOTO | 2024-08-31 | Yes | $11.06 | 3000pcs | $33180.0 | 15.13% | $5020.14 |
![]() | B0G21PYJ76 | Band-Aid | 2026-02-28 | Yes | $9.29 | 4000pcs | $37160.0 | 11.27% | $4187.94 |
![]() | B08F9Y9GBV | Dimora | 2020-08-05 | Yes | $16.09 | 700pcs | $11263.0 | 29.03% | $3269.65 |
![]() | B0DCBY1LQ2 | Promifun | 2024-12-12 | Yes | $15.99 | 600pcs | $9594.0 | 30.08% | $2885.88 |
![]() | B07WR4G3S7 | Dr. Frederick's Original | 2019-08-18 | Yes | $12.99 | 700pcs | $9093.0 | 27.15% | $2468.75 |
B0BNNB3CHY | Niceful | 2022-11-30 | Yes | $20.42 | 300pcs | $6126.0 | 33.73% | $2066.3 | |
![]() | B0CXXZP6QJ | Welnove | 2024-03-13 | Yes | $15.71 | 400pcs | $6284.0 | 29.47% | $1851.9 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0G227RM3L | Band-Aid | 2025-11-12 | Yes | $12.93 | 4000pcs | $51720.0 | 23.18% | $11988.7 |
![]() | B0GHSNJPP2 | Viybtue | 2026-01-20 | Yes | $16.9 | 3000pcs | $50700.0 | 19.27% | $9769.89 |
![]() | B0FMDGFLXP | Arme | 2025-08-24 | Yes | $9.61 | 6000pcs | $57660.0 | 15.07% | $8689.37 |
![]() | B0G21PYJ76 | Band-Aid | 2026-02-28 | Yes | $9.29 | 4000pcs | $37160.0 | 11.27% | $4187.94 |
![]() | B0GMT2CG8J | MakeItSkin | 2026-02-01 | Yes | $14.99 | 300pcs | $4497.0 | 30.17% | $1356.75 |
![]() | B0FK9WGBM3 | JL CARE | 2025-09-07 | Yes | $11.59 | 100pcs | $1159.0 | 23.2% | $268.89 |
这个市场不值得进入,属于明显拥挤且接近价格战的高风险市场。新品牌的成功率只有18.75%,但真正能站住脚的只有少数且都依赖明确差异化;同时新品牌失败率高达81.25%,老品牌也只有11.11%的新品成功率,说明新人和大品牌都在同一条窄路里厮杀。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
结论:这个市场不值得进入,已经进入严重价格战/拥挤区,新品牌成功率太低。 近期新进入产品里盈利只有16.67%,而全部新发布产品盈利率也只有14.71%,非盈利占82.35%;同时近一年新品牌几乎都在失败,说明现在不是增量市场,而是高强度内卷市场。
从时间看,市场明显在变难。2025年新发布里只有3个盈利、13个不盈利;到2026年,盈利只剩2个,不盈利9个,最新一批月度数据里大多数新货都落在“other/未达标”或亏损区,几乎看不到持续改善的迹象。更关键的是,近期真正跑出来的不是“干净的新小品牌”,而是 Band-Aid、Viybtue、JL CARE、Arme、MakeItSkin 这些品牌的少数成功款;其中像 B0G21PYJ76、B0G227RM3L、B0GHSNJPP2、B0FK9WGBM3、B0FMDGFLXP、B0GMT2CG8J 只是零星成功,撑不起“容易复制”的机会。按预算看,市场建议的新产品启动资金约 2474.85 美元,你的 500000 CNY 足够做单个ASIN启动,但钱够不代表能赢,因为这个类目里大量失败款集中在老牌和新牌,说明还需要额外的品牌、内容、认证和持续投放成本。
对大品牌来说,能打,但要非常重的投入,而且只能围绕少数既有强势品牌做对标;对小企业来说,机会很差,因为“真小品牌”没有形成可验证的稳定成功案例,反而失败样本大量集中在 Promifun、Band-Aid、FELXIESS、JL CARE、MedVance、Arme、OK TAPE 等品牌的新发布上,且不少品牌单月/单年新款都落在非盈利区。如果你没有明显差异化、品牌背书和持续广告预算,这个市场不要进。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 2 | 0 | 1 | 2 | 0 | 0 | 16 |
| 2026 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 12 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 |
| 2025/9 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| 2025/11 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 4 |
| 2025/12 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 |
| 2026/1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4 |
| 2026/2 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |